Table 2 Characteristics and demographics of patients
Total (n = 248) | |
|---|---|
Ages, mean ± SD in years | 60.2 ( ± 16.5) |
Female, n (%) | 146 (59) |
BMI mean ( ± SD) | 27.2 ( ± 6.7) |
Etiology, n (%) | |
Bipolarity | 176 (71.0) |
Depressive syndrome | 32 (12.9) |
Schizophrenia | 21 (8.5) |
Mixed anxiety-depressive disorder | 11 (4.4) |
Unknown | 3 (1.2) |
Others | 5 (2.0) |
Duration on lithium in years (mean ± SD) (n = 236) | 10.6 ( ± 10.9) |
Number of patients with lithium blood level | 115 (46.3) |
Lithium blood level (mEq/L) | 0.9 ( ± 0.8) |
< 0.5 (n = 36) | 0.3 ( ± 0.1) |
[0,5–0,8] (n = 36) | 0.6 ( ± 0.1) |
]0,8–1,20] (n = 25) | 1.0 ( ± 0.1) |
> 1,2 (n = 18) | 2.3 ( ± 1.0) |
Extended-release formulation, n (%) | 199 (80.2) |
Diabetes Mellitus, n (%) | 34 (14) |
Hypertension, n (%) | 80 (32) |
GFR in ml/min (mean ± SD) (n = 243) | 77.5 ( ± 31.9) |
Stage 1 ≥ 90 (n = 102) | 106 ( ± 11.4) |
Stage 2 60–89 (n = 71) | 76.8 ( ± 8.8) |
Stage 3 30–59 (n = 47) | 45.4 ( ± 9.1) |
Stage 4 15–29 (n = 15) | 24.3 ( ± 4.1) |
Stage 5 < 15 (n = 8) | 9.7 ( ± 2.9) |